Vladimir Vexler - 01 Apr 2022 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Chief Scientific Officer
Signature
/s/ McDavid Stilwell, as Attorney-in-Fact for Vladimir Vexler
Issuer symbol
CHRS
Transactions as of
01 Apr 2022
Net transactions value
-$44,435
Form type
4
Filing time
05 Apr 2022, 17:19:29 UTC
Previous filing
12 Jan 2022
Next filing
06 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Tax liability $44,435 -3,458 -3.2% $12.85 103,963 01 Apr 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").